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1. INTRODUCTION 
Herbal medicine is the oldest form of healthcare known to mankind. Herbs had been used 
by all cultures throughout history. It was an integral part of the development of modern 
civilization. Primitive man observed and appreciated the great diversity of plants available to 
him. The plants provided food, clothing, shelter, and medicine. Much of the medicinal use of 
plants seems to have been developed through observations of wild animals and by trial and error. 
As time went on, each tribe added the medicinal power of herbs in their area to its knowledge 
base. They methodically collected information on herbs and developed well-defined herbal 
pharmacopoeias. Indeed, well into the 20th century much of the pharmacopoeia of scientific 
medicine was derived from the herbal lore of native peoples. Many drugs commonly used today 
are of herbal origin. Indeed, about 25% of the prescription drugs dispensed in the United States 
contain at least one active ingredient derived from plant material. Some are made from plant 
extracts; others are synthesized to mimic a natural plant compound.1 
Undisputedly, the history of herbology is inextricably intertwined with that of modern 
medicine. Many drugs listed as conventional medications were originally derived from plants. 
Salicylic acid, a precursor of aspirin, was originally derived from white willow bark and the 
meadowsweet plant. Cinchona bark is the source of malaria-fighting Quinine. Vincristine, used 
to treat certain types of cancer, comes from Periwinkle. The Opium poppy yields morphine, 
codeine, and paregoric, a treatment for diarrohea Laudanum, a tincture of the Opium poppy, was 
the favored tranquilizer in Victorian times. Even today, Morphine-the most important alkaloid of 
the Opium poppy-remains the standard against which new synthetic pain relieves is measured. 
Prior to the discovery and subsequent synthesis of antibiotics, the herb Echinacea (which 
comes from the plant commonly known as purple coneflower) was one of the most widely 
prescribed medicines in the United States. For centuries, herbalists prescribed Echinacea to fight 
infection. Today, research confirms that the herb boosts the immune system by stimulating the 
production of disease-fighting white blood cells.2, 3 
The use of plants as medicine is older than recorded history. As mute witness to this fact 
marshmallow root, hyacinth, and yarrow have been found carefully tucked around the bones of a 
Stone Age man in Iraq. These three medicinal herbs continue to be used today. Marshmallow 
root is a demulcent herb, soothing to inflamed or irritated mucous membranes, such as a sore 
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throat or irritated digestive tract. Hyacinth is a diuretic that encourages tissues to give up excess 
water. Yarrow is a time-honored cold and fever remedy that may once have been used much as 
aspirin is today. 
The entire Middle East has a rich history of herbal healing. There are texts surviving from 
the ancient cultures of Mesopotamia, Egypt, and India that describe and illustrate the use of 
many medicinal plant products, including castor oil, linseed oil, and white poppies. In the 
scriptural book of Ezekiel, which dates from the sixth century B.C., we find this admonition 
regarding plant life: “ the fruit thereof shall be for meat, and leaf thereof for medicine”. Egyptian 
hieroglyphs show physicians of the first and second centuries A.D. treating constipation with 
Senna pods, and using Caraway and Peppermint to relieve digestive upsets.4 
 
Herbal Medicine Today 
The World Health Organization (WHO) estimates that about 80% of the world population 
presently use herbal medicine for some aspect of primary health care. Herbal medicine is a major 
component in all indigenous people’s traditional medicine and a common element in Ayurvedic, 
Homeopathic, Naturopathic, traditional oriental, and native American Indian medicine. WHO 
notes that of 119 plant-derived pharmaceutical medicines, about 74% are used in modern 
medicine in ways that correlated directly with their traditional uses as plant medicines by native 
cultures. Major pharmaceutical companies are currently conducting extensive research on plant 
materials gathered from the rain forests and other places for their potential medicinal value. 
Rather than using a whole plant, pharmacologists identify, isolate, extract, and synthesize 
individual components, thus capturing the active properties. This can create problems, however. 
In addition to active ingredients, plants contain minerals, vitamins, volatile oils, glycosides, 
alkaloids, bioflavanoids and other substances that are important in supporting a particular herb's 
medicinal properties. These elements also provide an important natural safeguard. Isolated or 
synthesized active compounds can become toxic in relatively small doses. It usually takes a 
much greater amount of a whole herb, with all of its components, to reach a toxic level. Herbs 
aremedicines, however, and they can have powerful effects. They should not be taken lightly. 
The suggestions for herbal treatments in this book are not intended to substitute for consultation 
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with a qualified health care practitioner, but rather to support and assist you in understanding and 
working with your physician's advice.5 
Substances derived from the plants remain the basis for a large proportion of the 
commercial medications used today for the treatment of heart disease, high blood pressure, pain, 
asthma, and other problems. For example, Ephedra is an herb used in Traditional Chinese 
Medicine for more than two thousand years to treat asthma and other respiratory problems. 
Ephedrine, the active ingredient in Ephedra, is used in the commercial pharmaceutical 
preparations for the relief of asthma symptoms and other respiratory problems. It helps the 
patient to breathe more easily. 
Another example of the use of an herbal preparation in modern medicine is the Foxglove 
plant. This herb had been in use since 1775. At present, the powdered leaf of this plant is known 
as the cardiac stimulant digitalis to the millions of heart patients it keeps alive worldwide. 
There are over 750,000 plants on earth. Relatively speaking, only a very few of the 
healing herbs have been studied scientifically. And because modern pharmacology looks for one 
active ingredient and seeks to isolate it to the exclusion of all the others, most of the research that 
is done on plants continues to focus on identifying and isolating active ingredients, rather than 
studying the medicinal properties of whole plants. Herbalists, however, consider that the power 
of a plant lies in the interaction of all its ingredients. Plants used as medicines offer synergistic 
interactions between ingredients both known and unknown. 
The efficacy of many medicinal plants has been validated by scientist’s abroad, from 
Europe to the orient. Thanks to modern technology, science can now identify some of the 
specific properties and interactions of botanical constituents. With this scientific documentation, 
we now know why certain herbs are effective against certain conditions. However, almost all of 
the current research validating herbal medicine has been done in Germany, Japan, China, 
Taiwan, and Russia. And for the most part, the United States Food and Drug Administration 
(FDA), which is responsible for licensing all new drugs (or any substances for which medicinal 
properties are claimed) for use in the United States, does not recognize or accept findings from 
across the sea. Doctors and government agencies want to see American scientific studies before 
recognizing the effectiveness of a plant as medicine. Yet even though substantial research is 
being done in other countries, drug companies and laboratories in the United States so far have 
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not chosen to put much money or resources into botanical research. The result is that herbal 
medicine does not have the same place of importance or level of acceptance in this country as it 
does in other countries. 6 
 
Alternative System of Medicine 
 Failure to control stress-related environmental and psychological illness, history of 
surgical accidents and growing resistance to antibiotics, people are looking for alternative 
medicines. Moreover, there are some chronic illnesses such as asthma, arthritis, irritable bowl 
syndrome, migraine, insomnia, immunodeficiency, cancer, jaundice, which do not have effective 
conventional treatment. Majority of the patient with cancer or acquired immunodeficiency 
syndrome are currently using one or more alternative therapies. Negative side effects of 
conventional treatment are also encouraging people to look for alternative system of medicine. 
Above all, after the FDA’s decision to categorize herbal remedies as food supplements, the 
popularity of herbal products is increasing day by day. There is no restriction and one can buy 
over the counters. Advertising and promotion of these products cannot separate myths from 
reality and give a ray of hope to some patients. Hence, estimates of herbal medicine sales 
skyrocketed to between $2 and $3 billion.  
 It has been estimated that 70-90% of the world’s population relies on alternative therapies 
and practices. Moreover, many types of alternative therapies are a formal approach to healthcare 
in various societies and culture around the world. If a particular therapeutic approach has not 
originated by American health care it does not render it worthless, quackery or fad. Most 
alternative therapies have evolved from ancient healing system in various cultures around the 
world and are based on reasonable scientific background. There must be some truth in it. As 
science catches up with human behavior some types of alternative therapies are being found 
useful.7 
 
Demand of Herbal Medicine 
  Despite the dramatic advancement and advantages of conventional medicines herbal drug 
have much to offer? Today, herbal drugs are coming back into prominence. Side effects of the 
conventional medicines such as antibiotics, antimicrobial agents are the major problems. Over 
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the years, some of the infectious organisms have developed resistance to synthetic drugs too. 
Medicinal chemist is taking for more potent and effective drugs hence more complications. 
            Herbals are used in the art of healing since the time immemorial. The primitive man 
through trial and error gained knowledge of herbal and passed it on to the next progeny. It is 
reasonable to assume that for ten thousands of year herbs were perhaps used for the magical 
power as well as for their medicinal values. 
 Despite the development in modern medicines, the use of herbs is still increasing, why? 
For thousands of year herbs and other products from the natural source have been used in 
treating various diseases. Some of those in current use have been an ancient heritage, whereas 
other has arisen from discoveries and cultural trend in more recent centuries. All therapy referred 
to as alternative or complementary came from outside the main stream.8,9  
 
Role of medicinal plants in anticancer treatment  
Cancer is the abnormal growth of cells in our bodies that can lead to death. Cancer cells 
usually invade and destroy normal cells. These cells are born due to imbalance in the body and 
by correcting this imbalance, the cancer may be treated. Billions of dollars have been spent on 
cancer research and yet we do not understand exactly what cancer is. Every year, millions of 
people are diagnosed with cancer, leading to death. According to the American Cancer Society, 
deaths arising from cancer constitute 2–3% of the annual deaths recorded worldwide. Thus 
cancer kills about 3500 million people annually all over the world. Several chemopreventive 
agents are used to treat cancer, but they cause toxicity that prevents their usage10. 
 
In India, there are atleast 250,000 species of plants out of which more than one thousand 
plants have been found to possess significant anticancer properties.Cancer is often deadly and 
affects a considerable number of people worldwide. Ongoing research is being done throughout 
the world to seek out effective treatments for cancer, including the use of plants to relieve and 
treat cancer patients. This treatment makes use of the compounds naturally present in plants that 
are known to inhibit or kill carcinogenic cells. An alternative to chemotherapy, which is the most 
common means by which doctors and specialists treat cancer, organically based treatments may 
not have the severe side effects that radial treatments and chemotherapy has. The harsh side 
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effects of cancer treatments is one motivating factor to finding alternative methods. The use of 
botanical when treating cancer patients is considered a natural alternative, because some plants 
may contain properties that naturally have the ability to prevent the spread or risk of developing 
various forms of cancer. As in all medical testing, careful precautions and considerations are 
taken when studying the different compounds present in plants that are known to treat cancer.  
 
Some examples of plants that may be used for cancer treatment are discussed below with their 
respective advancements. There are around 460 species of plants that can be used as herb for 
remedy, including plant healer various types of cancer.Various types of anti-cancer plant are 
Zedoary (Curcumazedoaria), Rodent Tuber(Typhoniumflagelliforme), God’s Crown 
(Phaleriamacrocarpa), Madagaskar Periwinkle (Catharanthusroseus), Artocarpus Integer 
(Selaginellacorymbosa), Bamboo Grass LoathatreumGràcies), handsome 
(Taraxacummongolicum), fruit makasar (Bruccajavanica), Garlic (Alliumsativum), Echo China 
(Smilaxchina), Sunflower (Helianthusannus), Leunca (Solanumnigrum), Job’s Tears 
(CoixLachryma-Jobi), Bamboo Rope (Asparaguscochinchinensis), and others11. 
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TUMOR12: 
 Neoplasia literally means the process of "new growth," and a new growth is called a 
neoplasm. The term tumor was originally applied to the swelling caused by inflammation. 
Neoplasms also may induce swellings, but by long precedent, the non-neoplastic usage of tumor has 
passed into limbo; thus, the term is now equated with neoplasm. Oncology (Greek oncos = tumor) is 
the study of tumors or neoplasms. Cancer is the common term for all malignant tumors. Although 
the ancient origins of this term are somewhat uncertain, it probably derives from the Latin for crab, 
cancer-presumably because a cancer "adheres to any part that it seizes upon in an obstinate manner 
like the crab."  
1. DEFINITIONS: 
Solid tumors are defined as abnormal masses of tissue that usually do not contain cysts or 
liquid areas. Solid tumors may be benign (not cancerous), or malignant (cancerous). A number of 
malignant diseases are often also categorized as “solid tumors” such as breast cancer, cancer of 
the pancreas, lung, colon, etc. 
 
 Solid tumors can be split into three separate categories, depending on the type of cells from 
which they typically arise in the patient’s body, which include: 
 Sarcomas: Cancers arising from connective or supporting tissues such as bone or 
muscle. 
 Carcinomas: Cancers arising from the body's glandular cells and epithelial cells, which 
line the air passages and gastrointestinal tract. 
 Lymphomas: Cancers of the lymphoid organs such as lymph nodes, spleen, and thymus, 
which produce and store infection-fighting cells. Lymphoma is cancer of the lymphatic 
system, which is part of the immune system.  
Definition 
 
Breast cancer is caused by the development of malignant cells in the breast. The malignant cells 
originate in the lining of themilk glands or ducts of the breast (ductal epithelium), defining this m
alignancy as a cancer. Cancer cells are characterized byuncontrolled division leading to abnorma
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l growth and the ability of these cells to invade normal tissue locally or to spreadthroughout the b
ody, in a process called metastasis. 
 
 
Description 
Breast cancer arises in the milkproducing glands of the breast tissue. Groups of glands in normal 
breast tissue are calledlobules. The products of these glands are secreted into a duct system that l
eads to the nipple. Depending on where in theglandular or ductal unit of the breast the cancer aris
es, it will develop certain characteristics that are used to subclassifybreast cancer into types. The 
pathologist will note the subtype at the time of evaluation with the microscope. Ductalcarcinoma 
begins in the ducts, lobular carcinoma has a pattern involving the lobules or glands. The more im
portantclassification is related to the evaluated tumor's capability to invade, as this characteristic 
defines the disease as a truecancer. The stage before invasive cancer is called in situ, meaning tha
t the early malignancy has not yet become capable ofinvasion. Thus, ductal carcinoma in situ is c
onsidered a minimal breast cancer.The International Agency for Research on Cancer estimates of 
the incidence of mortality and prevalence from major types of cancer, at national level, for 184 
countries of the world revealed that there were 14.1 million new cancer cases, 8.2 million cancer 
deaths, and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 
worldwide 13.By 2030, it is projected that there will be 26 million new cancer cases and 17 
million cancer deaths per year 14 
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How breast cancer spreads? 
The primary tumor begins in the breast itself, but once it becomes invasive, it may progress beyo
nd the breast to the regionallymph nodes or travel (metastasize) to other organ systems in the bod
y and become systemic in nature. Lymph is the clear,proteinrich fluid that bathes the cells throug
hout the body. Lymph will work its way back to the bloodstream via smallchannels known as ly
mphatics. Along the way, the lymph is filtered through cellular stations known as nodes, thus the
y arecalled lymph nodes. Nearly all organs in the body have a primary lymph node group filterin
g fluid that comes from that organ.In the breast, the primary lymph nodes are under the armpit, o
r axilla. Classically, the primary tumor begins in the breast andthe first place to which it is likely 
to spread is the regional lymph nodes. Cancer, as it invades in its place of origin, may alsowork it
s way into blood vessels. If cancer gets into the blood vessels, the blood vessels provide yet anot
her route for thecancer to spread to other organs of the body.Breast cancer follows this classic pr
ogression though it often becomes systemic or widespread early in the course of thedisease. By t
he time one can feel a lump in the breast it is often 0.4 inches, or one centimeter, in size and cont
ains roughly amillion cells. It is estimated that a tumor of this size may take one to five years to d
evelop. During that time, the cancer maymetastasize, or spread by lymphatics or blood to areas el
sewhere in the body. 
When primary breast cancer spreads, it may first go to the axillary nodes. If this occurs, regional 
metastasis exists. If itproceeds elsewhere either by lymphatic or bloodborne spread, the patient d
evelops systemic metastasis that may involve anumber of other organs in the body. Favorite sites
 of systemic involvement for breast cancer are the lung, bones, liver, skin,and soft tissue. As it tu
rns out, the presence of, and the actual number of, regional lymph nodes containing cancer remai
nsthe single best indicator of whether or not the cancer has become widely metastatic. Because te
sts to discover metastasis inother organs may not be sensitive enough to reveal minute deposits o
f cancer cells, the evaluation of the axilla for regionalmetastasis becomes very important in maki
ng treatment decisions for this disease.If breast cancer spreads to other major organs of the body,
 its presence will compromise the function of those organs. Deathis the result of extreme compro
mise of vital organ function. 
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TYPES OF BREAST CANCER. 
 Ductal carcinoma in situ: The most common type of noninvasive breast cancer is 
ductal carcinoma in situ (DCIS). This type of cancer has not spread and therefore usually 
has a very high cure rate. 
 Invasive ductal carcinoma: This cancer starts in a duct of the breast and grows into the 
surrounding tissue. It is the most common form of breast cancer. About 80% of invasive 
breast cancers are invasive ductal carcinoma. 
 Invasive lobular carcinoma: This breast cancer starts in the glands of the breast that 
produce milk. Approximately 10% of invasive breast cancers are invasive lobular 
carcinoma. 
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 The remainder of breast cancers are much less common and include the following: 
 Mucinous carcinoma are formed from mucus-producing cancer cells. Mixed tumors 
contain a variety of cell types. 
 Medullary carcinoma is an infiltrating breast cancer that presents with well-defined 
boundaries between the cancerous and noncancerous tissue. 
 Inflammatory breast cancer: This cancer makes the skin of the breast appear red and feel 
warm (giving it the appearance of an infection). These changes are due to the blockage of 
lymph vessels by cancer cells. 
 Triple-negative breast cancers: This is a subtype of invasive cancer with cells that lack 
estrogen and progesterone receptors and have no excess of a specific protein (HER2) on 
their surface. It tends to appear more often in younger women and African-American 
women. 
 Paget's disease of the nipple: This cancer starts in the ducts of the breast and spreads to 
the nipple and the area surrounding the nipple. It usually presents with crusting and 
redness around the nipple. 
 Adenoid cystic carcinoma: These cancers have both glandular and cystic features. They 
tend not to spread aggressively and have a good prognosis. 
 Lobular carcinoma in situ: This is not a cancer but an area of abnormal cell growth that 
can lead to invasive breast cancer later in life. 
RISK FACTORS13-14   
 Modifiable risk factor( thing that people can change themselves such as consumption of 
alcoholic beverages). 
 Fixed risk factors (( thing that people cannot changed, such as age and biological sex). 
 Smoking increase the risk of breast cancer. 
 A number of dietary factors have been linked to the risk of breastcancer. 
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Symptoms of cancer 
The symptoms and signs of lymphoma are very similar to those of simple illnesses such 
as viral illnesses and the common cold, and this can cause problems with delayed diagnosis. 
The difference is that the symptoms of lymphoma persist long after the usual run of a viral 
infection. 
 Weight loss and loss of appetite 
 Unusual itching 
 Fatigue 
 Pain or altered sensation 
 Loss of appetite 
 Breathlessness 
 Enlarged tonsils 
Treatments and prevention15 
A number of treatment options are used against lymphoma cancer these are 
 Radiation therapy 
 Biologic therapy 
 Antibody therapy 
 Stem-cell transplantation 
 Steroid treatment 
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CANCER CELL LINES AS A MODEL FOR CANCER STUDY15 
Cancer cell lines have been widely used for research purposes and proved to be a useful tool in 
the genetic approach, and its characterization shows that they are, in fact, an excellent model for 
the study of the biological mechanisms involved in cancer. The use of cancer cell lines allowed 
an increment of the information about the deregulated genes and signalling pathways in this 
disease . Furthermore, the use of the cell model was in the origin of the development and testing 
of anticancer drugs presently used and in the development of new therapies , but also as an 
alternative to transplantable animal tumours in chemotherapeutics testing . In fact, the use of the 
appropriate in vitro model in cancer research is crucial for the investigation of genetic, epigenetic 
and cellular pathways  for the study of proliferation deregulation, apoptosis and cancer 
progression , to define potential molecular markers  and for the screening and characterization of 
cancer therapeutics. The results of the research in cancer cell lines are usually extrapolated to in 
vivo human tumours and its importance as models for drug testing and translational study have 
been recognized by many biomedical and pharmaceutical companies. 
 
Cancer cell line  Species   Morphology 
HeLa Homo sapiens  Cervix 
adenocarcinoma  
Epithelial  
MCF-7 Homo sapiens Breast 
adenocarcinoma 
Epithelial  
U87MG Homo sapiens Glioblastoma-
astrocytoma 
Epithelial  
HT-29 Homo sapiens Colon 
adenocarcinoma 
Epithelial  
A549 Homo sapiens Lung carcinoma Epithelial  
HEP-G2 Homo sapiens Hepatocellular 
carcinoma 
Epithelial  
K-562 Homo sapiens Chronic myeloid 
leukaemia 
Lymphoblas 
Cos7 Homo sapiens SV40 transformed 
- kidney 
Fibrobla 
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2. LITERATURE REVIEW 
 History of Medicine goes back practically to the existence of human being. The 
currentaccepted Modern Medicine or Allopathy has gradually been developed over the years by 
thescientific observational efforts of scientists. However, the basis of its development remains in 
theroots of traditional medicine and therapies. The history of medicine includes many 
ludicroustherapies. Nevertheless, the ancient wisdom has been the basis of modern medicine and 
willremain as one of the important source of future medicine and therapeutics. The future will be 
more holistic, personal and involve wise-use of ancient and modern therapeutic skills in 
acomplementary manner so that maximum benefits will go to the patients and the community. 
Medical system has a broad meaning. It incorporates diagnosis, prognosis and 
prevention.Treatment has a definite rational and philosophy. Therapies have a limited meaning 
referring tomainly treatment. Within this framework of definition, two prominent systems of 
medicine withhistory of existence for thousands of years include Indian system of medicine such 
as Siddha,Ayurveda, etc. and Chinese Medicine. Ayurveda incorporates Yoga while Chinese 
medicineincludesAcupuncture.Systematic literature survey is the main basis for the planning of 
any scientific work and due to this the review of literature regarding the cayratiacarnosa (wall 
.ex. wight) gengap.has been examined and reported. They are in following manner 
pharmacogonostical, phytochemical and pharmacological review. 
 
Shah et al. (1970) has done micro-histogenic studies on tendrils on vitaeace16. 
 
Duthieet al.(1980) has reported presence of delphinidin and cyanidin in the leaves of  
cayratiacarnosa (wall.ex. wight) gengap17. 
Singh et al. (1982) has reported yellow waxy oil and sterols in the leaves of Cayratiacarnosa 
(wall.ex. wight) gengap17. 
 
Patilet al. (2000) has been done the phytochemical studies and found the   presence of lignins , 
tannins, raphides, mucilaginous substances and flavonoids in  CayratiaCarnosa (wall.ex. wight) 
gengap18. 
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Perumalet al. (2014) identified a novel PPARγ agonist from GC-MS analysis of ethanolic 
extract of Cayratia trifolia19. 
Perumalet al. (2015) performed the Isolation, structural characterization and in silico drug-like 
properties prediction of bioactive compound from ethanolic extract of Cayratia trifolia20.  
 
Pharmacological  review: 
Kunduet al. (2000) investigated the Antitumor activity of epifriedelanol from Vitistrifolia. 
Fitoterapia21. 
Gupta et al. (2012)Evaluated the gastric anti-ulcer activity of methanolic extract of 
Cayratiatrifolia in experimental animals22. 
 
Perumalet al. (2012).Studied the Invitro antioxidant activities and HPTLC analysis of ethanolic 
extract of Cayratia trifolia23. 
 
Sowmyaet al. (2015) investigated the In vitro Antioxidant Activity, In vivo Skin Irritation 
Studies and HPTLC Analysis on extracts of Cayratiatrifolia24. 
 
Palanisamyet al. (2016) studied theAssessment of dual inhibitory activity of epifriedelanol 
isolated from Cayratiatrifolia against ovarian cancer. They reported the properties of the 
epifriedelanol and scope to develop the compound as a potent anti-ovarian cancer drug25. 
 
Miscellaneous review: 
Patilet al. (2005) has been done preliminary evaluation of indigenous wild  grapegermplasm for 
infestation of caterpillar26.  
Herbs with cytotoxic studies  
Ahmed et al. (2003) reportedthe chemotherapeutic and chemoprotective effects of extract of 
Nigella sativa which is containing anticancer principles of quinones that include thymoquinone 
(TQ) and dithymoquinone27. 
Jain et al. (2011) evaluated the cytotoxic effect of five alcoholic plant extracts on MCF-7 and 
HL-60 cells using MTT assay. MTT Different dilutions of extracts were treated and IC50 values 
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were calculated. From their study, they concluded that the S. grandiflorabark extract has potent 
in vitrocytotoxic activity against cancer cell lines28. 
Punithaet al. (2012) studied the cytotoxicity of ethanolic leaf extracts of 
Gmelinaarborea(Verbenaceae) was tested against Colon cancer (COLO 201), Gastric cancer 
(HT-29) and Human oesophagel cancer (TE-2) cell lines using the thiazolyl blue test (MTT) 
assay29.  
Rani et al. (2013) evaluated the anticancer property of the elected four seaweeds viz., 
SargasssumwightiiGreville, PadinatetrastromaticaHauck, UlvafaciataDelile and             
GracillariaedulisandP.C. Silvafrom the south east coast of India. The cytotoxic activity was 
determined against human A-549 lung adenocarcinoma cancer cell lines and VERO (African 
green monkey kidney cells) non‐cancerous cell line using the MTT method30.  
Sumathiet al. (2013) performed thecomparative study of the apoptosis influencing activity of 
methanolic extract of Prosopis cineraria leaves in breast cancer cell line MCF-731. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
17 
Department of Pharmacology                                                  J.K.K.Nataraja College of Pharmacy 
                           3.  PLANT PROFILE 32-35 
 
BOTANICAL NAME:  Cayratiatrifolia(wall .ex. wigh&Arn) gagnep. 
Synonym : Cayratiacarnocagagnep. 
CissusauriculataRoxb. 
Vitiscarnosa 
Vitistrifolia 
Taxonomy
 
   Kingdom  : Plantae 
   Subkingdom  : Viridaeplantae 
   Phylum  : TracheophytaSinnott,  
   Subphylum  : Spermatophytina (auct.)  
 Infraphylum  : Angiospermaeauct. 
   Class   : MagnoliopsidaBrongniart 
    Subclass  : Rosidae 
   Superorder  : Vitanae 
   Order   : Vitales 
  Family  : Vitaceae 
  Genus   : Cayratia 
   Species  : CarnosaGagnepain 
 
Description 
A somewhat fleshy climbing shrub,usually pubescent when young,tendrils short, slender 
and branched,leaves trifoliate, usually pubescent, lecillets dentate, flowers in branched, long 
peduncledcymes, flower buds globose,fruits fleshy berries,seeds pyriform or triangular , rounded 
and rugose on the back      
Habitat 
Throughout India on the hills, west coast and western charts in India.This species are 
globally distributed in Indo-Malesia. Within India, it is found in the hotter parts from Jammu and 
Rajasthan, Assam, Tripura and West Bengal, extending into Peninsular India, up to an altitude of 
600 m. 
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Part Used 
Whole plant  
Chemical constituents 
Hydrocyanic acid, delphinidin and cyanidine 
BOTANTICAL CHARACTERS 
Stem 
Woody, compressed when young; tendrils short, slenderusuallybranched. 
Leaves 
Leaves are 3-foliolate,common petioles,2- 4.5cm. leaflets thick, 3.8-5.7 by 2.2-3.2cm. 
Ovate- lanceolate, more or less pubescent on both surface; main nerve 5-6 pairs; petioles of the 
lateral leaflets 3-6mn; stipules small, ovate acute 
Flower  
Flowers in branched divaricate  pubesecent long- peduncled  cymes; buds  globose; 
pedicals about 3 mm. long, calyx pubesent outside, funnel shaped, 4- lobed. Petals 4oblong. 
Seed 
Triangular, rounded and rugose on the back, cuneate on the face. 
Ethanomedicinal uses 
 The root has sharp sour taste used for “vata” and “Kapha”. 
 The plant is used for the treatment of tumors, pains and spleen complaints (Ayurveda). 
 The plant is used for purification of blood (Yunani). 
 The plant is used for dropsy, wounds, ulcer and cardiac disorder.  
 It has been also used in the treatment of yoke sores on the necks of bullocks for that 
purpose, a poultice of the leaves is employed. 
 Leaves are used in embrocating. 
 Fermentations with hot decoction is recommended in fever. 
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 4. AIM AND SCOPE OF STUDY 
 
As we know very well that everything in this world change time by time, since thousands 
of years the era was of Ayurveda or herbal origin drug. But last few decades, it was replaced by 
allopathic system of medicine, which was accepted worldwide but later due to its lots of adverse 
effect again men step down on Ayurveda because of its better therapeutic result and safety 
profile and now the people are more believing in natural origin drugs. But prior clinical trial; of 
medicinal drug preparation and proper pharmacological and toxicological studies are required to 
ensure the safety of the drug. 
 
The present work focused the comprehensive study ofcayratiacarnosa (wall.ex.wight) 
gengap. The ethnobotanical review showed that the entire plant has potent medicinal properties 
such as wound healing, analgesic, anti-inflammatory, antiulcer and antitumor properties. Till 
now, few phytochemical studies has been done on this plant. Therefore, this plant having wide 
scope for detail pharmacogonostical, preliminary phytochemical and pharmacological 
investigation. 
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5. PLAN OF WORK 
 
The plan of work on the present studyincludes the following. 
 
1. Priliminary Phytochemical studies 
a. Preparation of extracts 
b. Qualitative phytohemical analysis 
2. Pharmacological studies 
a. Invitroanti cancerstudies  
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6. MATERIALS AND METHODS 
6.1 PROCEDURE: 
                         Fresh mixture  werecollected and was dried. After drying they were again 
pulverized. The size is reduced. The dried plant CayratiatrifoliaGagnep, powder mixture was 
weighed about 250g Extracted by soxhlet apparatus using 99% of ethanol and water  as a solvent 
for 72 hours. The yield of product was 7.358g. 
Collection of Specimen 
The species for the proposed study that is cayratiacarnosa (wall .ex. 
wight&Arn.)Gagnep.familyVitaceae was collected  from surroundings of vattamalai, 
Komarapalayam. Further it was identified and authenticated by Dr. P. Jayaraman, Botanist, 
Thambaram, Chennai.  
 
6.2 IDENTIFICATION OF PHYTOCHEMICAL CONSTITUTENTS 
6.2.1 PRELIMINARY PHYTOCHEMICAL TESTS : 
 
The plant may be considered as a biosynthetic laboratory, not only for the chemical 
compounds such as Carbohydrates, Protein and Lipids that are utilized as food by men, but also 
for a multitude of compounds like Glycosides, Alkaloids, Volatile oils, Tannins etc., that exerts a 
physiologic effect. The compounds that are responsible for therapeutic effect are usually the 
secondary metabolites. A systemic study of a crude drug embraces through consideration of both 
primary and secondary metabolites derived as a result of plant metabolism. The plant material 
may be subjected to preliminary phytochemical screening for the detection of various plant 
constituents.  
 
 For our present study, we had taken the plant material as powdered plant 
ofCayratiatrifoliaGagnep. To extract the compounds are tested the chemical constituents present 
in them. 
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6.3 PREPARATION OF EXTRACTS 
Preparation of the extracts ofCayratiatrifoliaGagneppowdered plant by using following 
solvents: 
 
(a) Ethanol  
(b) Distilled Water 
 
(a) Ethanol extract 
The shade dried course powder of the entire plant (250 gm) was packed well in soxhlet 
apparatus and was subjected for continuous hot extraction with 99.99% ethanol until the 
completion of the extraction. The extract was filtered while hot and the resultant extract was 
distilled in vacuum under reduced pressure in order to remove the solvent completely. Dried and 
kept in a desiccator till experimentation. Obtained extract (dark blackish brown) was weighed 
and percentage yield was calculated in terms of air-dried powdered crude material (ethanolic 
extract was named as ETE). 
 
(b) Aqueous extract 
The shade dried course powder of the entire plant (250 gm) was packed well in soxhlet 
apparatus and was subjected to continuous hot extraction with distilled water until the 
completion of extraction. The extract was filtered while hot and the resultant extract was distilled 
in vacuum under reduced pressure in order to remove the distilled water completely. It was 
finally dried and kept in a desiccator till experimentation. Obtained extract (dark reddish brown) 
was weighed and percentage yield was calculated in terms of air-dried powdered crude material 
(ethanolic extract was named as AQE). 
 
 
6.2 QUALITATIVE PHYTOCHEMICAL ANALYSIS 
 
Both ethanolic and aqueous extracts obtained from the powdered 
plantCayratiatrifoliagagnep .were subjected to various qualitative tests for the identification of 
various plant constituents present in this species. 
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1. Test for Alkaloids 
(a) Dragendorff’s Test:  To 1 ml of the extract, add 1 ml of dragendorff’s reagent (Potassium 
Bismuth iodide solution). An orange-red precipitate indicates the presence of alkaloids. 
(b) Mayer’s Test:  To 1 ml of the extract, add 1 ml of mayer’s reagent (Potassium mercuric 
iodide solution). Whitish yellow or cream colored precipitate indicates the presence of alkaloids. 
(c) Hager’s Test:  To 1 ml of the extract, add 3ml of Hager’s reagent (Saturated Petroleum Ether 
solution of picric acid), yellow colored precipitate indicates the presence of alkaloids. 
(d) Wagner’s Test  :  To 1 ml of the extract, add 2 ml of wagner’s reagent (Iodine in Potassium 
Iodide), Formation of reddish brown precipitate indicates the presence of alkaloids. 
 
2. Test for Saponins 
 Take small quantity of alcoholic and aqueous extract separately and add 20 ml of distilled 
water and shake in a graduated cylinder for 15 minutes lengthwise. A 1cm layer of foam 
indicates the presence of saponins. 
 
3. Test for Glycosides 
(a) Legal Test:  Dissolve the extract in pyridine and add sodium nitroprusside solution to make 
it alkaline. The formation of pink red to red color shows the presence of glycosides. 
(b) Baljet Test:  To 1ml of the test extract, add 1ml of sodium picrate solution and the yellow to 
orange color reveals the presence of glycosides. 
 (c) Keller-KillianiTest  :  1gm of powdered drug is extracted with 10ml of 70% alcohol for 2 
minutes, filtered, add to the filtrate, 10ml of water and 0.5ml of strong solution of lead acetate 
and filtered and the filtrate is shaken with 5ml of chloroform. The chloroform layer is separated 
in a porcelein dish and removes the solvent by gentle evaporation. Dissolve the cooled residue in 
3ml of glacial acetic acid containing 2 drops of 5% ferric chloride solution. Carefully transfer 
this solution to the surface of 2ml of concentrated sulphuric acid. A reddish brown layer forms at 
the junction of the two liquids and the upper layer slowly becomes bluish green, darkening with 
standing. 
(d )Borntrager’s Test :  Add a few ml of dilute sulphuric acid to 1ml of the extract solution. 
Boil, filter and extract the filtrate with chloroform. The chloroform layer was treated with 1ml of 
  
24 
Department of Pharmacology                                                  J.K.K.Nataraja College of Pharmacy 
ammonia. The formation of red color of the ammonical layer shows the presence of 
anthraquinone glycosides. 
 
4. Test for Carbohydrates and Sugars 
(a) Molisch’s Test:  To 2ml of the extract, add 1ml of -napthol solution, add concentrated 
sulphuric acid through the side of the test tube. Purple or reddish violet colour at the junction of 
the two liquids reveals the presence of Carbohydrates. 
(b) Fehling’s Test  :  To 1ml of the extract, add equal quantities of Fehling solution A and B, 
upon heating formation of a brick red precipitate indicates the presence of sugars 
(c) Benedict’s test:  To 5ml of Benedict’s reagent, add 1ml of extract solution and boil for 2 
minutes and cool. Formation of red precipitate shows the presence of sugars. 
 
5. Test for Phenolic Compounds and Tannins 
a) Take the little quantity of test solution and mixed with basic lead acetate solution. Formation 
of white precipitates indicates the presence of tannins. 
b) To 1ml of the extract, add ferric chloride solution, formation of a dark blue or greenish black 
colour product shows the presence of tannins. 
c) The little quantity of test extract is treated with potassium ferric cyanide and ammonia 
solution. A deep red colour indicates the presence of tannins. 
d) To the test extract, add strong potassium dichromate solution, a yellow colour precipitate 
indicates the presence of tannins and phenolics. 
 
6. Test for Flavonoids 
a) The drug in alcoholic and aqueous solution with few ml of ammonia is seen in U.V. and 
visible light, formation of fluorescence indicates the presence of flavonoids. 
b) Little quantity of extract is treated with amyl alcohol, sodium acetate and ferric chloride. A 
yellow colour solution formed, disappears on addition of an acid indicates the presence of 
flavonoids. 
c) Shinoda’s Test:  The alcoholic extract of powder treated with magnesium foil and 
concentrated HCl give intense cherry red color indicates the presence of flavonones or 
orange red colour indicates the presence of flavonols. 
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d) The extract is treated with sodium hydroxide, formation of yellow colour indicates the 
presence of flavones. 
e) The extract is treated with concentrated H2SO4, formation of yellow or orange colour 
indicates flavones. 
f) The alcoholic and aqueous extract is treated with 10% sodium chloride; formation of yellow 
colour indicates the presence of coumarins. 
 
7. Test for Steroids and Sterols 
(a) Libermann-BurchardTest :  1gm of the test substance was dissolved in a few drops of 
chloroform, 3ml of acetic anhydride, 3ml of glacial acetic acid were added, warmed and cooled 
under the tap and drops of concentrated sulphuric acid were added along the sides of the test 
tube. Appearance of bluish-green colour shows the presence of sterols. 
(b) Salkowski Test:  Dissolve the extract in chloroform and add equal volume of conc. 
H2SO4 .Formation of bluish red to cherry colour in chloroform layer and green fluorescence in 
the acid layer represents the steroidal components in the tested extract. 
 
8. Test for Proteins and Amino Acids 
Biuret Test: Add 1ml of 40% sodium hydroxide solution and 2 drops of 1%  CuSO4 solution till 
a blue color is produced, then add to the 1ml of the extract. Formation of pinkish or purple violet 
colour indicates the presence of proteins. 
Ninhydrin Test:  Add two drops of freshly prepared 0.2% ninhydrin reagent (0.1% solution in 
n-butanol) to the small quantity of extract solution and heat. Development of blue colour reveals 
the presence of proteins, peptides or amino acids. 
Xanthoproteic Test: To 1ml of the extract, add 1ml of concentrated nitric acid. A white 
precipitate formed, it was boiled and cooled. Then 20% of sodium hydroxide or ammonia is 
added. Orange colour indicates the presence of aromatic amino acids. 
(a) Millon’s Test:  1ml of test solution is made acidify with sulphuric acid and add millon’s 
reagent and boil this solution. A yellow precipitate is formed indicates the presence of protein. 
 
9.Test for Triterpenoids 
(a) Noller’s Test:  Dissolve two or three granules or tin metal in 2ml thionyl chloride 
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solution. Then add 1ml of the extract into test tube and warm, the formation of pink colour 
indicates the presence of triterpenoids. 
 
10. Test for Fixed Oils and Fats 
(a) Spot Test:  Press a small quantity of extracts between the filter paper. Oil stains on paper 
indicates the presence of fixed oils. 
(b) Saponification test:  To 1ml of the extract, add few drops of 0.5 N alcoholic Potassium 
hydroxide along with a drop of phenolphthalein. Heat the mixture on a water bath for 1-2 hours. 
The formation of soap or partial neutralization of alkali indicates the presence of fixed oils and 
fats. 
 
11. Test for Gums and Mucilage 
(a) Add about 10ml of alcoholic extract slowly to 25ml of absolute alcohol with constant stirring. 
Filter the precipitate and dry in air. Examine the precipitate for its swelling properties and for the 
presence of carbohydrates. 
 
12. Test for Lignins: With alcoholic solution of phloroglucinol and hydrochloric acid, the 
appearance of red colour shows the presence of lignins. 
The constituents present in extracts of powdered plant ofCayratiatrifoliagagnep   are 
given in table no - 6.  
 
6.4 INVITRO ANTICANCER STUDIES   
 
Among the various diseases attributed to mortality in humans all over the world, cancer is 
a leading cause. It was estimated that there were 10.9 million new cases, 6.7 million deaths, and 
24.6 million persons living with cancer around the world (166). There is a necessity for search of 
new compounds with cytotoxic activity as the treatment of cancer with the available anticancer 
drugs is often unsatisfactory due to the problem cytotoxicity to the normal cells.  
Plants have a long history of use in the treatment of cancer. Several studies have been 
conducted on herbs under a multitude of ethnobotanical grounds. Over the past few decades a 
significant progress has been made in cancer prevention and treatment. Plant-derived natural 
products are becoming important as anti-cancer derivatives, including vincristine, vinblastine, 
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paclitaxel and camptothecin, which are invaluable contributors of nature to modern medicine38-
41
.    
In recent years, in vitro toxicology has rapidly developed into a challenging new 
scientific discipline. Some of the complications occur during in-vivo cytotoxic screening that is 
intravenous administration of chemotherapeutic drugs cause significant individual differences in 
biotransformation and bio-distribution. To overcome this problem, in-vitro cytotoxic screenings 
are used in which the effect of chemotherapeutic drug is being studied in the tumor cells in 
culture outside the body. Also, in vitro toxicity tests have gained the support of many animal 
welfare organizations, and are seen as one of the most promising means whereby the reduction 
and replacement of animal usage can be achieved42-44.  
Principle: 
The principle of this colorimetric assay is based on the capacity of mitochondria 
succinate dehydrogenase enzymes in living cells to reduce the yellow water soluble substrate 3- 
(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) into an insoluble, blue 
colored formazan product which is measured spectrophotometrically (174-175). Only viable 
cells with active mitochondria reduce significant amounts of MTT since the reduction of MTT 
can only occur in metabolically active cells, the level of activity is a measure of the viability of 
the cells.  
Media: 
Leibovitz L-15 Medium with L-Glutamine, FBS (Fetal Bovine Serum, SFM HEK-293 
(Serum Free Media), Thioglycollate medium (TGM), Tryptone soya broth (TSB) and Cell 
proliferation kit (MTT) 1000 tests. 
Cell lines:  
MCF-7 (Breast cancer cell line) was purchased from NCCS, Pune.  
Cell treatment procedure45-48: 
Cytotoxicity of the plant extract on the MCF-7 breast cancer cell lines was determined 
using the MTT Proliferation assay kit. The cells in a concentration of 1×10 cells/ml were 
preincubated in culture medium for 3 hrs at 37 °C and 6.5 % CO2. The cells were seeded at a 
concentration of 5×104 cells/well in 100 μl culture medium and at various concentrations (5 -100 
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μg/ml) of standard Methotrexate and extract (dissolved in 2 % DMSO (dimethyl sulphoxide) 
solution) into microplates (tissue culture grade, 96 wells, flat bottom) and incubated for 24 hrs at 
37 °C and 6.5 % CO2.  
The test denotes the survival cells after toxic exposure. Then, 10 μl MTT labeling 
mixtures were added and incubated for 4 hrs at 37 °C and 6.5 % CO2. Each experiment was done 
in triplicates. Then 100μl of solubilisation solution was added into each well and incubated for 
overnight. The spectrophotometric absorbance of the samples was measured using a microplate 
(ELISA) reader at a wavelength in between 550 and 600 nm according to the filters available for 
the ELISA reader. The reference wavelength should be more than 650 nm. Percentage inhibition 
of extract against all cell lines was calculated using the following formula: 
% of cell survival = AT/AC x 100 
AT– Absorbance of test  
AC – absorbance of control 
% of cell inhibition = 100 - % cell survival  
The IC50 value, i.e., the concentration required to inhibit 50% of cell viability was 
determined by plotting the log of the drug concentration versus the percentage of inhibition. The 
best-fit line was plotted by least-squares linear regression. The 50% inhibitory concentration 
(IC50) was calculated from the linear-regression equation: Log (CV50) = m×log (IC50)+c; where 
m is the regression coefficient, c is the intercept of the line, log (IC50) is the log of the 50% 
inhibitory concentration of the extract and log (CV50) is the log value of 50% cell viability. 
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7.        RESULTS AND DISSCUSSION 
 The plant CayratiatrifoliaGagnepbelonging to family Vitaeceae was selected for the 
project. On the basis of ethanobotanical information, which reveals its uses against disease like 
wound, inflammation, fever, tumor etc. Literature survey showed that very less work has been 
performed on this plant.So we can validate scientifically for folk claim for its therapeutic 
activity. We have also undertakes its detailed, preliminary phytochemical and invitro 
pharmacological investigation to give an appropriate identification and rationalize its use as drug 
of therapeutic importance. 
 
Preliminary phytochemical studies preformed by starting with purification of solvents. 
Then powdered whole plant CayratiatrifoliaGagnepwere subjected for continuous hot extraction 
with ethanol and distilled water. The yield was found to be 10.24 %w/w for ethanolic extract 
(ETE) and 16.2%w/w for aqueous extract (AQE).  These extracts were subjected to various 
qualitative phytochemical tests to identify the active constituents which showed presence of 
Alkaloids, Glycosides, Saponins, Carbohydrates, Tannin & Phenolic compounds, Triterpinoids, 
Steroids, Flavonoids, Fixed oil and fats. Ethanolic extract showed the presence of Alkaloids, 
Glycosides, Saponins, Carbohydrates, Tannins & Phenolic compounds Triterpinoids, Steroids, 
Flavonoids, Fixed oil and fats, Gum and mucilage and Lignins ,whereas the aqueous extract 
showed, presence of Glycosides, carbohydrates, Tannin, Phenolic compounds, Flavonoids and 
Lignins.  
The yield and % yield of both ethanolic and aqueous extracts of powdered plant 
ofCayratiatrifoliagagnep were reported. 
TABLE NO. 1 - EXTRACTION VALUES OF ETHNOLIC AND AQUEOUS EXTRACTS 
OFCAYRATIA TRIFOLIA  GAGNEP. 
 
S. No. 
Extracts 
Yield (gms.) % Yield (w/w) 
1. Ethanol Extract (ETE) 25.60 10.24 
2. Aqueous Extract (AQE) 40.64 16.2 
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TABLE NO. -2 
DATA FOR   PRELIMINARY PHYTOCHEMICAL ANALYSIS OF ETHANOLIC AND 
AQUEOUS EXTRACTS OFEXTRACTS OF CAYRATIA TRIFOLIAGAGNEP. 
 
In vitro cytotoxic studies against MCF-7 breast cancer cell line by MTT assay 
Cytotoxicity potential of AQE and ETE, extracts were determined using MTT assay 
against MCF-7 breast cancer cell line. A significant increase in the % of cytotoxic value of the 
AQE andETEtreated cells were noted when compared to the standard. The IC50 for cytotoxicity 
was found to be the standard was 29.68µg/ml and cells treated with ETE were 37.51 μg/ml 
being the most potent inhibitor. AQE treated cells indicated an IC50 value of 40.6 μg/ml. The 
highest percentage inhibition was found to 97%, 92% and 86% for Standard drug Methotrexate, 
Phytoconstituents Ethanolic extract Aqueous extract 
Alkaloids + - 
Saponins + - 
Glycosides + + 
Carbohydrates + + 
Tannins,Phenolic compounds + + 
Flavonoids + + 
Steroids + + 
Proteins and Amino acids - - 
Triterpenoids + - 
Fixed Oils and Fats + - 
Gums and Mucilage + - 
Lignins + + 
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Aqueous Extract and Ethanolic Extract respectively. However, the percentage inhibition of 
cytotoxicity was found to be lower for both the extracts AQE and ETE when compared to the 
standard drug methotrexate. In addition, ETE showed better inhibition than the AQE. The 
R2value for the standard, AQE & ETE were 0.9755, 0.9560 & 0.9485 respectively.   
 
ABSORPTION DATA OF STD, AQE & ETETABLE :3 
 
Absorbance at 570 nm 
STD 
Absorbance at 570 nm 
AQE 
Absorbance at 570 nm 
ETE 
0.2469 0.0041 00042 
0.1646 0.0457 0.0042 
0.1881 0.0582 0.0295 
0.2195 0.0915 0.0885 
0.2508 0.1373 0.1349 
0.2900 0.1831 0.1812 
0.2979 0.1997 0.1897 
0.2979 0.2330 0.2065 
0.3136 0.2663 0.2571 
0.3175 0.2788 0.2571 
0.3253 0.2996 0.2866 
0.3371 0.3246 0.2951 
0.3371 0.3287 0.3246 
0.3488 0.3454 0.3330 
0.3528 0.3454 0.3372 
0.3528 0.3579 0.3372 
0.3567 0.3704 0.3499 
0..3645 0.3787 0.3499 
0.3645 0.3787 0.3583 
0.3920 0.4162 0.4216 
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TABLE. 4 
CYTOTOXIC ACTIVITY OF STANDARD AND EXTRACTS AGAINST MCF-7 
BREAST CANCER CELL 
Con. 
(μg/ml) Log.Con 
%inhibition of  
STD 
%inhibition of 
AQE 
%inhibition of 
ETE 
5 0.69897 37 2 2 
10 1 43 12 2 
15 1.17609 49 15 8 
20 1.30103 57 23 22 
25 1.39794 65 34 33 
30 1.47712 75 45 44 
35 1.54407 77 49 46 
40 1.60206 77 57 50 
45 1.65321 81 65 62 
50 1.69897 82 68 62 
55 1.74036 84 73 69 
60 1.77815 87 79 71 
65 1.81291 87 80 78 
70 1.8451 90 84 80 
75 1.87506 91 84 81 
80 1.90309 91 87 81 
85 1.92941 92 90 84 
90 1.95424 94 92 84 
95 1.97972 94 92 86 
100 2 97 92 86 
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Cytotoxic activity of standard and extracts against MCF-7 breast cancer cell line 
Invitro cytotoxic studies on STD, AQE & EET (Fig. 18) 
 
 
 
 
TABLE.5 
LINEAR EQUATION, R2 AND IC50 VALUES OF STD, AQE & ETE  
S.No. Sample Linear equation R2 IC50 value 
1 STD (Methotrexate) Y = 50.277*x- 3.866 0.9755 29.68µg/ml 
2 AQE Y = 82.689*x-72.67 0.9560 40.6 µg/ml 
3 ETE Y = 80.644*x-73.96 0.9485 37.51µg/ml 
 
 
 
 
 
y = 50.277x - 3.8666 
R² = 0.9755 
y = 82.689x - 72.672 
R² = 0.956 
y = 80.644x - 73.962 
R² = 0.9485 
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The compounds of Tannins & Phenolic compounds Triterpinoids, Steroids and 
Flavonoids have been reported in ETE. The literatures proved that these compounds are potent 
antioxidants and free radical scavengers. The antioxidant, antimicrobial, and antitumor activities 
due to its phenolic, flavanoid and aromatic compounds. These beneficial substances can act as 
antioxidants and electrophile scavengers, stimulate the immune system, form the DNA addicts 
with carcinogens and induce detoxification enzymes. Hence, the reported cytotoxic activity of 
ETE may be due to the presence of polyphenolic compounds and antioxidant potential of the 
extracts. 
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8. CONCLUSIONS 
The ethanolic and aqueous extracts of CayratiatrifoliaGagnepbelonging to family 
Vitaeceaewere found to possess moderate cytotoxic potential with reference to the standard drug 
Methotrexate against MCF-7 breast cancer cell line. Among the extracts, the ethanolic extract 
showed better activity than the aqueous extract when comparing with standard.  
The reported cytotoxic activity of the plant extracts in the present study may be due to the 
presence of phenolic and flavonoid constituents. This indicates the possibility of the plant 
extracts investigated for further development to cancer therapeutic agent and warrants further 
studies to understand the mechanisms of cytotoxic activity of the plant extract 
CayratiatrifoliaGagnep. 
However, the isolation of active principle will be advantageous to produce novel 
bioactive constituent from this extract which may possess more significant activity.   
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